These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8828953)

  • 1. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience.
    De Vita S; Ferraccioli GF; Di Poi E; Bartoli E; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S85-92. PubMed ID: 8828953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous immunoglobulin (IVIG)].
    Hara M
    Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases].
    Laghi Pansini F; Capecchi PL; Bellisai F; Lazzerini PE; Galeazzi M
    Reumatismo; 2003; 55(4):209-19. PubMed ID: 14872219
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin therapy for rheumatic diseases.
    Sany J
    Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins in Still's disease: still controversial, still unproven.
    Prieur AM
    J Rheumatol; 1996 May; 23(5):797-800. PubMed ID: 8724286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous immunoglobulins in the systemic autoinmune diseases].
    Gómez-Puerta JA; Cucho Venegas M; Cervera Segura R; Font Franco J
    Rev Clin Esp; 2003 Nov; 203(11):548-54. PubMed ID: 14599398
    [No Abstract]   [Full Text] [Related]  

  • 7. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
    Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
    Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adult-onset Still's disease with pulmonary and cardiac involvement and response to intravenous immunoglobulin].
    Neto NS; Waldrich L; de Carvalho JF; Pereira RM
    Acta Reumatol Port; 2009; 34(4):628-32. PubMed ID: 20087268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs.
    Vignes S; Wechsler B; Amoura Z; Papo T; Francès C; Huong DL; Veyssier P; Godeau P; Piette JC
    Clin Exp Rheumatol; 1998; 16(3):295-8. PubMed ID: 9631752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
    Zandman-Goddard G; Levy Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy: magic or black magic.
    Barron KS; Sher MR; Silverman ED
    J Rheumatol Suppl; 1992 Apr; 33():94-7. PubMed ID: 1593608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E; Kessel A; Shoenfeld Y
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
    Zandman-Goddard G; Blank M; Shoenfeld Y
    Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy in rheumatic diseases.
    Bayry J; Negi VS; Kaveri SV
    Nat Rev Rheumatol; 2011 Jun; 7(6):349-59. PubMed ID: 21556030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticosteroid resistance thrombocytopenia in connective tissue disorders and vasculitis].
    Rezuş E; Rezuş C; Răşcanu A; Bârzoi R; Rodica C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):267-74. PubMed ID: 17802930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new alternative therapy in dermatology: tocilizumab.
    Koryürek ÖM; Kalkan G
    Cutan Ocul Toxicol; 2016; 35(2):145-52. PubMed ID: 26023856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin.
    Sciascia S; Giachino O; Roccatello D
    Clin Exp Rheumatol; 2012; 30(3):409-13. PubMed ID: 22513222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
    Chighizola CB; Ong VH; Meroni PL
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):401-423. PubMed ID: 27515671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Still disease in adults with intravenous immunoglobulins].
    Permal S; Wechsler B; Cabane J; Perrot S; Blum L; Imbert JC
    Rev Med Interne; 1995; 16(4):250-4. PubMed ID: 7746963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence.
    Rodriguez MM; Wagner-Weiner L
    Pediatr Ann; 2017 Jan; 46(1):e19-e24. PubMed ID: 28079914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.